TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153,895 | +3.1% | 4,081 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $149,292 | -18.0% | 3,936 | +143.1% | 0.00% | 0.0% |
| Q3 2017 | $182,000 | +5.8% | 1,619 | +5.5% | 0.00% | 0.0% |
| Q2 2017 | $172,000 | -3.9% | 1,535 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $179,000 | +24.3% | 1,535 | +12.2% | 0.00% | 0.0% |
| Q4 2016 | $144,000 | -99.9% | 1,368 | -2.7% | 0.00% | 0.0% |
| Q3 2016 | $155,377,000 | -24.1% | 1,406 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $204,714,000 | +205.5% | 1,406 | +196.6% | 0.00% | – |
| Q1 2016 | $67,000,000 | -69.0% | 474 | -66.2% | 0.00% | -100.0% |
| Q4 2015 | $216,000,000 | +194494.6% | 1,401 | +80.5% | 0.00% | – |
| Q3 2015 | $111,000 | -99.9% | 776 | +32.6% | 0.00% | – |
| Q2 2015 | $84,058,000 | +57.7% | 585 | +54.8% | 0.00% | – |
| Q1 2015 | $53,309,000 | +80.8% | 378 | +89.9% | 0.00% | – |
| Q4 2014 | $29,490,000 | +248.5% | 199 | +261.8% | 0.00% | – |
| Q3 2014 | $8,462,000 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |